Search Results 1991-2000 of 19678 for Hemoglobin

  1. A Study To Test The Addition Of The Drug Cabozantinib To Chemotherapy In Patients With Newly Diagnosed Osteosarcoma - Mayo Clinic

    Hemoglobin >= 8.0 g/dL (within 7 days prior to enrollment unless otherwise indicated). International normalized ratio (INR) =< 1.5 (within 7 days prior to ...

  2. Heart Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to test if a reduction of hemoglobin leads to subclinical cardiac dysfunction in patients with known cardiovascular disease. A ...

  3. Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN), unless due to Gilbert's disease;; Aspartate transaminase (AST/serum glutamic ...

  4. Publications - Stanimir Vuk-Pavlovic, Ph.D. - Mayo Clinic

    From hemoglobin structure to cancer immunotherapy: A very personal account. Period Biol. 2003 Sep; 105(3):201-5. Antica M, Kusic B, Hranilovic D, Dietz AB ...

  5. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

    Hemoglobin (Hgb) <10 g/dL; Absolute Neutrophil Count (ANC) <1500/mm³. Must have Stage III or Stage IV disease. Baseline measurements/evaluations obtained ...

  6. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Hemoglobin < 9 g/dL. Female subject who is pregnant, breastfeeding or considering becoming pregnant during the study or within 30 days after the last dose ...

  7. Oncology (Medical) - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  8. A Study to Evaluate the Safety, Tolerability and Metabolism of BIIB105 in Subjects with Amyotrophic Lateral Sclerosis - Mayo Clinic

    mellitus defined as hemoglobin A1c (HbA1c) ≥8% during Screening. - In participants in Cohorts A, B, and C1, prescreening ALSFRS-R slope >-0.4 points/month ...

  9. MEDI5395 Advanced Solid Tumors - Clinical Trials

    Hemoglobin ≥ 9 g/dL;; Platelets ≥ 100,000/μL;; Hepatic ALT ≤ 2.5 × ULN;; AST ≤ 2.5 × ULN;; TBL ≤ 1.5 × ULN [≤ 3 × ULN if the subject has documented ...

  10. Belantamab, Lenalidomide, and Daratumumab for Newly-diagnosed Multiple Myeloma - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1200/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase ...